Integrin Receptor Antagonists [MoA] - N0000175774

Pharmacologic Code	N0000175774
Pharmacologic Name	Integrin Receptor Antagonists
Pharmacologic Uses	integrin receptor antagonist
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

The table contains 4 products whose active ingredient are classified under the same pharmacologic class Integrin Receptor Antagonists [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	64406-008	Tysabri	Non-Proprietary Name: Natalizumab	Injection	Intravenous	Biogen Inc.	ACTIVE
	64764-107	Entyvio	Non-Proprietary Name: Vedolizumab	Injection, Solution	Subcutaneous	Takeda Pharmaceuticals America, Inc.	ACTIVE
	64764-108	Entyvio Pen	Non-Proprietary Name: Vedolizumab	Injection, Solution	Subcutaneous	Takeda Pharmaceuticals America, Inc.	ACTIVE
	64764-300	Entyvio	Non-Proprietary Name: Vedolizumab	Injection, Powder, Lyophilized, For Solution	Intravenous	Takeda Pharmaceuticals America, Inc.	ACTIVE